BioShai is developing PDx, a simple blood test for the early diagnosis of Parkinsons disease. PDx is based on the measurement of the level of expression of a set of genes. The test can be combined with other clinical data to provide a more complete diagnosis and help physicians decide on the best course of treatment.
BioShai is a portfolio company of Youdim Pharmaceuticals incubator.
Cumulative Funding Raised Over Time ($)
Employees Over Time
BioShai Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 17, 2016
www.israel21c.org
World's first blood test to aid diagnosis of Parkinson's